Construction of Mtb۷۲F Plasmid as a DNA Vaccine Candidate for Mycobacterium tuberculosis
Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 321
This Paper With 7 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_RBMB-6-1_013
تاریخ نمایه سازی: 10 شهریور 1400
Abstract:
Background: With one-third of the world’s population infected, tuberculosis (TB) is one of the most common infectious diseases and a major public health problem, especially in developing countries. The efficacy of the BCG vaccine for controlling the disease in adults is poor. The development of an effective TB vaccine is a global objective. An effective tuberculosis vaccine should stimulate cellular immunity. DNA vaccines are a new generation of vaccines with the potential to achieve this goal. The aim of this study was to produce a DNA vaccine of Mtb۷۲F.
Methods: mtb۳۲C, mtb۳۹, and mtb۳۲N were cloned into pcDNA۳.۱ using restriction enzyme digestion and T۴ DNA ligase. Colony-PCR and restriction enzyme digestion were performed to detect transformed bacteria. DNA sequencing confirmed the desired gene insertion into the vector. A Chinese hamster ovary (CHO) cell line was transfected with the recombinant plasmid and RT-PCR was performed to assess gene expression.
Results: Gel electrophoresis showed the expected amplified gene fragments of ۴۲۹, ۶۱۴, and ۱۲۰۰ base pairs (bps) for mtb۳۲C, mtb۳۲N, and mtb۳۹, respectively. Enzyme digestion and gel electrophoresis showed the expected fragments, indicating the desired gene position and orientation in the recombinant plasmid. This finding was verified by DNA sequencing, and RT-PCR demonstrated gene expression in the CHO cell line.
Conclusions: An Mtb۷۲F DNA plasmid was successfully constructed. This plasmid may be a candidate for animal immunizations.
Keywords:
Authors
Maryam Sadat Nabavinia
Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Mohammad Ramezani
Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Aida Gholoobi
Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahboubeh Naderinasab
Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Zahra Meshkat
Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :